Free Trial
OTCMKTS:HYPMY

Hypermarcas Earnings Date & Estimates

Hypermarcas logo
$4.00 -0.11 (-2.56%)
As of 11:48 AM Eastern

Hypermarcas is estimated to report earnings on Wednesday, November 11, 2026, after market closes.

Upcoming Earnings Announcement

Announcement Date
Time
After Market Closes

What Analysts Expect from Hypermarcas

Hypermarcas is expected to post earnings of $0.14 per share on revenue of $450.75 million. In the same quarter a year earlier Hypermarcas reported $0.13 per share on revenue of $408.83 million. Hypermarcas last reported on August 6, 2026, posting $0.14 per share and beating the $0.13 consensus estimate.

Consensus Estimates

Consensus EPS
$0.14
Expected Revenue
$450.75 million
Prior-Year EPS
$0.13
Prior-Year Revenue
$408.83 million
Expected EPS Growth
+7.7%
Expected Revenue Growth
+10.3%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.14 (Beat by +$0.01)

Hypermarcas Earnings FAQ

Hypermarcas (OTCMKTS:HYPMY) is estimated to report earnings on Wednesday, November 11, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Analysts expect Hypermarcas to post earnings of $0.14 per share for the quarter.

The consensus revenue estimate for Hypermarcas is $450.75 million for the quarter.

Hypermarcas Earnings Headlines

Hypermarcas (HYPMY) Set to Announce Quarterly Earnings on Wednesday
Contrasting Trulieve Cannabis (NYSE:TRLV) & Hypermarcas (OTCMKTS:HYPMY)
What the hell is going on?
Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.tc pixel
Hypera ON ADR (HYPMY) Hisse Fiyatı Bugün Ne Kadar?
Hypera S.A. (HYPMY) Q3 2026 Earnings Call Transcript
Hypera ON ADR (HYPMY)
See More Hypermarcas Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Hypermarcas? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hypermarcas and other key companies, straight to your email.

About Hypermarcas

Hypermarcas (OTCMKTS:HYPMY) was a Brazilian consumer-products and pharmaceutical company that later adopted the name Hypera Pharma. The company refocused its operations on pharmaceuticals after divesting a number of businesses in other consumer-goods categories.

Today, Hypera Pharma develops, manufactures and markets medicines in Brazil, including prescription drugs, over-the-counter products and branded generics. Its portfolio also includes vitamins and supplements, and it sells products under brands such as Neo Química and Mantecorp.

The company is based in Brazil and serves the domestic market through its pharmaceutical operations. Its evolution from a diversified consumer-products group into a pharmaceutical-focused business is an important part of Hypermarcas’ corporate history.

View Hypermarcas Profile